GLYKERIA ROUVA

Dr. GLYKERIA ROUVA

University Hospital of Heraklion, Heraklion, Greece
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Eleni VergadiEleni Vergadi
Eleni Vergadi
GRGLYKERIA ROUVA
GLYKERIA ROUVA
MAMaria Angeli
Maria Angeli
EGEmmanouil Galanakis
Emmanouil Galanakis
Background: Desert dust outbreaks and dust storms are the major source of particulate matter globally and pose a major threat to human health. We investigated the microorganisms transported with desert dust particles and evaluated their potential impact on human health. Methods: A systematic review of all reports on the association between non-anthropogenic desert dust pollution, dust microorganisms and human health is conducted. Results: In total, 51 articles were included in this review. The affected regions studied were Asia (32/51, 62.7%) followed by Europe (9/51, 17.6%), America (6/51, 11.8%), Africa (4/51, 7.8%) and Australia (1/51, 2.0%). The Sahara Desert was the most frequent source of dust, followed by Asian and American deserts. In 39/51 studies the dust-related microbiome was analyzed, while, in 12/51 reports, the association of desert dust with infectious disease outbreaks was examined. Pathogenic and opportunistic agents were isolated from dust in 24/39 (61.5%) and 29/39 (74.4%) of the studies, respectively. A significant association of dust events with infectious disease outbreaks was found in 10/12 (83.3%) reports. The infectious diseases that were mostly investigated with dust outbreaks were pneumonia, respiratory tract infections, COVID-19, pulmonary tuberculosis and coccidioidomycosis. Conclusions: Desert dust outbreaks are vehicles of a significant number of pathogenic or opportunistic microorganisms and limited data indicate an association between dust events and infectious disease outbreaks. Further research is required to strengthen the correlation between dust events and infectious diseases and subsequently guide preventive public health measures.

9 November 2021 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
GRGLYKERIA ROUVA
GLYKERIA ROUVA
Eleni VergadiEleni Vergadi
Eleni Vergadi
EGEmmanouil Galanakis
Emmanouil Galanakis

13 October 2022 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
MAMaria Angeli
Maria Angeli
MBMaria Bitsori
Maria Bitsori
GRGLYKERIA ROUVA
GLYKERIA ROUVA
EGEmmanouil Galanakis
Emmanouil Galanakis

16 October 2024 in Acta Paediatrica
Verified
Journal Article
Open access
GRGLYKERIA ROUVA
GLYKERIA ROUVA
EVEleni Vergadi
Eleni Vergadi
KKKonstantinos Krasagakis
Konstantinos Krasagakis
EGEmmanouil Galanakis
Emmanouil Galanakis
Aim: The aim of this review was to summarise the current knowledge on host‐related factors that contribute to the development and severity of staphylococcal scalded skin syndrome (SSSS) in children.Methods: A comprehensive assessment and analysis of the existing literature on SSSS clinical features, pathogenesis and susceptibility factors.Results: SSSS is a blistering skin disease caused by circulating exfoliative toxins (ETs) of Staphylococcus aureus (S. aureus), almost exclusively affecting infants, young children and immunocompromised individuals. ETs possess serine protease activity and target desmoglein‐1 (Dsg‐1) in the superficial epidermis. While the role of S. aureus ETs and site of action are well‐described, other host factors such as impaired immune responses to ETs, poor renal clearance and genetic factors are crucial for the onset of and/or the severity of SSSS in children.Conclusion: The fate of desmosomal fractions after cleavage by ETs, as well as the role of dermal inflammatory cell infiltrates remain to be elucidated.

Verified
Journal Article
Open access
PDF file
EBEvangelos Blevrakis
Evangelos Blevrakis
Eleni VergadiEleni Vergadi
Eleni Vergadi
MSMaria Stefanaki
Maria Stefanaki
IAIris Alexiadi-Oikonomou
Iris Alexiadi-Oikonomou
GRGLYKERIA ROUVA
GLYKERIA ROUVA
EGEmmanouil Galanakis
Emmanouil Galanakis
Multisystem inflammatory syndrome in children (MIS-C) may develop as a rare complication following COVID-19. MIS-C presentation varies substantially, but fever and gastrointestinal symptoms are the most prominent. Indeed, gastrointestinal involvement may be severe enough to present as acute abdomen, posing challenges to clinicians. We present herein the case of a healthy five-year-old male who presented with fever, vomiting, and abdominal pain, resembling acute abdomen. The patient had no history of SARS-CoV-2 infection or exposure, and MIS-C diagnosis was initially surpassed unnoticed. The patient underwent exploratory laparotomy that only revealed mesenteric lymphadenitis. Postoperatively, the patient met the clinical and laboratory diagnostic criteria of MIS-C. SARS-CoV-2 exposure was serologically confirmed and MIS-C treatment was commenced, resulting in defervescence and a satisfactory outcome. In young patients presenting with acute abdomen, surgeons should be aware of MIS-C, so that earlier diagnosis and appropriate treatment are made prior to surgical interventions.